Fiche centre
The First Affiliated Hospital of Soochow University
Suzhou — China
Essais liés15clinical trials
VilleSuzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06726577
Essais cliniques associés
15| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| CAR-T | SEP | Phase 2 | NCT03196830 | CAR-T for R/R B-NHL | COMPLETED |
| CART-19/22 | SEP | Phase 1/2 | NCT03614858 | CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia. | UNKNOWN |
| Recombinant staphylokinase | Maladie coronarienne | Phase 4 | NCT05410925 | OPTIMA-6 — Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction | RECRUITING |
| FARAPULSE™ PFA system and WATCHMAN LAAC Delivery Systems | Maladie coronarienne | À vérifier | NCT06686485 | OPTION-A — Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia | ACTIVE_NOT_RECRUITING |
| TP04HN106 | Sclérose latérale amyotrophique | Phase 1/2 | NCT06726577 | TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis | RECRUITING |
| ThisCART19A with Dose Level 1 | SEP | Phase 1 | NCT05691153 | ThisCART19A for B-NHL Relapsed After Auto-CAR T | UNKNOWN |
| Skeletal muscle biopsy (residual specimen) | Myopathies | À vérifier | NCT06101940 | Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1) | ENROLLING_BY_INVITATION |
| M5049 low dose | Lupus | Phase 2 | NCT05540327 | The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) | ACTIVE_NOT_RECRUITING |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |
| Adagrasib | Cancer | Phase 3 | NCT06875310 | A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT06641466 | A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine | RECRUITING |
| LCAR-AIO T cells | SEP | Phase 1 | NCT06869278 | A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases | WITHDRAWN |
| Rimegepant | Migraine | Phase 3 | NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | ACTIVE_NOT_RECRUITING |
| Rimegepant/BHV3000 | Migraine | Phase 3 | NCT04649242 | Randomized Study in Children and Adolescents With Migraine: Acute Treatment | RECRUITING |
| Fenebrutinib | SEP | Phase 3 | NCT04586010 | FENhance — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING |